254 related articles for article (PubMed ID: 12114430)
1. Clinicopathological significance of loss of heterozygosity on chromosome 13q in hepatocellular carcinoma.
Wong CM; Lee JM; Lau TC; Fan ST; Ng IO
Clin Cancer Res; 2002 Jul; 8(7):2266-72. PubMed ID: 12114430
[TBL] [Abstract][Full Text] [Related]
2. High-density allelotyping of chromosome 8p in hepatocellular carcinoma and clinicopathologic correlation.
Chan KL; Lee JM; Guan XY; Fan ST; Ng IO
Cancer; 2002 Jun; 94(12):3179-85. PubMed ID: 12115350
[TBL] [Abstract][Full Text] [Related]
3. Identification of a 1-cM region of common deletion on 4q35 associated with progression of hepatocellular carcinoma.
Bando K; Nagai H; Matsumoto S; Koyama M; Kawamura N; Onda M; Emi M
Genes Chromosomes Cancer; 1999 Jul; 25(3):284-9. PubMed ID: 10379875
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive allelotype study of hepatocellular carcinoma: potential differences in pathways to hepatocellular carcinoma between hepatitis B virus-positive and -negative tumors.
Okabe H; Ikai I; Matsuo K; Satoh S; Momoi H; Kamikawa T; Katsura N; Nishitai R; Takeyama O; Fukumoto M; Yamaoka Y
Hepatology; 2000 May; 31(5):1073-9. PubMed ID: 10796882
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive allelotyping of well-differentiated human hepatocellular carcinoma with semiquantitative determination of chromosomal gain or loss.
Nishimura T; Nishida N; Itoh T; Kuno M; Minata M; Komeda T; Fukuda Y; Ikai I; Yamaoka Y; Nakao K
Genes Chromosomes Cancer; 2002 Dec; 35(4):329-39. PubMed ID: 12378527
[TBL] [Abstract][Full Text] [Related]
6. Relationship between loss of heterozygosity at microsatellite loci and computerized nuclear morphometry in hepatocellular carcinoma.
Suzuki K; Hirooka Y; Tsujitani S; Yamane Y; Ikeguchi M; Kaibara N
Anticancer Res; 2000; 20(2B):1257-62. PubMed ID: 10810431
[TBL] [Abstract][Full Text] [Related]
7. Deletion mapping of chromosome 16q in hepatocellular carcinoma.
Piao Z; Park C; Kim JJ; Kim H
Br J Cancer; 1999 May; 80(5-6):850-4. PubMed ID: 10360665
[TBL] [Abstract][Full Text] [Related]
8. [Detailed mapping and clinical significance of loss of heterozygosity on 9p13-23 in laryngeal squamous cell carcinoma by microsatellite analysis].
Xu XF; Tang PZ; Cheng SJ
Ai Zheng; 2003 May; 22(5):452-7. PubMed ID: 12753701
[TBL] [Abstract][Full Text] [Related]
9. Clonality analysis of multiple hepatocellular carcinomas by loss of heterozygosity pattern determined by chromosomes 16q and 13q.
Lin YW; Lee HS; Chen CH; Huang GT; Lee PH; Sheu JC
J Gastroenterol Hepatol; 2005 Apr; 20(4):536-46. PubMed ID: 15836701
[TBL] [Abstract][Full Text] [Related]
10. Concerted nonsyntenic allelic losses in hyperploid hepatocellular carcinoma as determined by a high-resolution allelotype.
Boige V; Laurent-Puig P; Fouchet P; Fléjou JF; Monges G; Bedossa P; Bioulac-Sage P; Capron F; Schmitz A; Olschwang S; Thomas G
Cancer Res; 1997 May; 57(10):1986-90. PubMed ID: 9157995
[TBL] [Abstract][Full Text] [Related]
11. Alterations of tumor suppressor genes and allelic losses in human hepatocellular carcinomas in China.
Fujimoto Y; Hampton LL; Wirth PJ; Wang NJ; Xie JP; Thorgeirsson SS
Cancer Res; 1994 Jan; 54(1):281-5. PubMed ID: 7903205
[TBL] [Abstract][Full Text] [Related]
12. Loss of heterozygosity and microsatellite instability in hepatocellular carcinoma in Taiwan.
Sheu JC; Lin YW; Chou HC; Huang GT; Lee HS; Lin YH; Huang SY; Chen CH; Wang JT; Lee PH; Lin JT; Lu FJ; Chen DS
Br J Cancer; 1999 May; 80(3-4):468-76. PubMed ID: 10408855
[TBL] [Abstract][Full Text] [Related]
13. Allelic loss on chromosome 1p is associated with progression and lymph node metastasis of primary breast carcinoma.
Tsukamoto K; Ito N; Yoshimoto M; Kasumi F; Akiyama F; Sakamoto G; Nakamura Y; Emi M
Cancer; 1998 Jan; 82(2):317-22. PubMed ID: 9445188
[TBL] [Abstract][Full Text] [Related]
14. Allelotype study of primary hepatocellular carcinoma.
Fujimori M; Tokino T; Hino O; Kitagawa T; Imamura T; Okamoto E; Mitsunobu M; Ishikawa T; Nakagama H; Harada H
Cancer Res; 1991 Jan; 51(1):89-93. PubMed ID: 1670995
[TBL] [Abstract][Full Text] [Related]
15. Genetic classification of combined hepatocellular-cholangiocarcinoma.
Fujii H; Zhu XG; Matsumoto T; Inagaki M; Tokusashi Y; Miyokawa N; Fukusato T; Uekusa T; Takagaki T; Kadowaki N; Shirai T
Hum Pathol; 2000 Sep; 31(9):1011-7. PubMed ID: 11014564
[TBL] [Abstract][Full Text] [Related]
16. Genomic instability in chronic viral hepatitis and hepatocellular carcinoma.
Dore MP; Realdi G; Mura D; Onida A; Massarelli G; Dettori G; Graham DY; Sepulveda AR
Hum Pathol; 2001 Jul; 32(7):698-703. PubMed ID: 11486168
[TBL] [Abstract][Full Text] [Related]
17. Frequent allelic losses on chromosomes 2q, 18q, and 22q in advanced non-small cell lung carcinoma.
Shiseki M; Kohno T; Nishikawa R; Sameshima Y; Mizoguchi H; Yokota J
Cancer Res; 1994 Nov; 54(21):5643-8. PubMed ID: 7923210
[TBL] [Abstract][Full Text] [Related]
18. [Genome-wide loss of heterozygosity analyses in primary hepatocellular carcinoma].
Li S; Wang H; Zhang C
Zhonghua Yi Xue Za Zhi; 2000 Aug; 80(8):577-81. PubMed ID: 11798820
[TBL] [Abstract][Full Text] [Related]
19. Loss of somatic heterozygosity in hepatocellular carcinoma.
Walker GJ; Hayward NK; Falvey S; Cooksley WG
Cancer Res; 1991 Aug; 51(16):4367-70. PubMed ID: 1678314
[TBL] [Abstract][Full Text] [Related]
20. Loss of heterozygosity at D8S298 is a predictor for long-term survival of patients with tumor-node-metastasis stage I of hepatocellular carcinoma.
Pang JZ; Qin LX; Ren N; Hei ZY; Ye QH; Jia WD; Sun BS; Lin GL; Liu DY; Liu YK; Tang ZY
Clin Cancer Res; 2007 Dec; 13(24):7363-9. PubMed ID: 18094418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
